Laddar populära aktier...
Q1: sales EUR 42m, +9% y-o-y, order intake EUR 40m, -5% y-o-y We lower '24e-'26e sales and order int...
Obducat AB (publ) (”Obducat” eller ”Bolaget”) levererade ett rekordår 2023, där Bolaget uppvisar en ...
As announced already in February, capacity utilization and turnover in Q1 were weighed down by the p...
Redeye returns with a more in-depth take on the Q1 report.
Redeye comments on Raketech’s Q1-results which were in line with the preliminary outcome that was an...
Redeye comments on Thunderful Group’s Q1'24 report, which was weak and came in line with preliminary...
Marimekko’s Q1 results came in stronger than expected driven partly by the timing of non-recurring w...
Sales -3%, EBIT +15%, order book -2% v.s. ABGSCe EBIT margin strengthened to 4.
Redeye provides an research update following Starbreeze Q1-report; Some positive comments from manag...
Redeye reiterates its positive stance following Physitrack’s Q1 results.
Redye provides a research update following the Q1 2024 report from Precise Biometrics.
Mixed markets; US strong but Germany weaker '24e-'26e EBIT down 4-3% on lowered Germany estimates Sh...
- Sales down 19% y-o-y in Q1 - Cost initiatives keep EBITA positive - Signs of a better market later...
Aspo held a CMD event on 14 May. The company is heading for EUR 1bn in net sales in 2028 which is al...
Paper EBITDA PLN 109m, in line vs ABGSCe PLN 108m Group EBITDA miss driven by Rottneros Paper market...